Novo CEO pressed by Senate to chop rates of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen explained to lawmakers the corporate would take into consideration new talks with insurers about the listing selling prices of Wegovy and copyright should they pledge to maintain the medicines on their own formularies. https://reidnrquz.blogdon.net/not-known-facts-about-healthcare-news-46841392